Seminers

On November 28th, 2015, Masahiro Nanjo will give a lecture on a theme “Patent Practice in Pharma Industry that Legal Department Must Know” for Legal Course of Lecture by Japan Pharmaceutical Industry Legal Affairs Association.

whatsnew_seminars_EN-2

On November 28th, 2015, Masahiro Nanjo will give a lecture on a theme “Patent Practice in Pharma Industry that Legal Department Must Know”  for Legal Course of Lecture by Japan Pharmaceutical Industry Legal Affairs Association. Legal Course of Lecture, Japan Pharmaceutical Industry Legal Affairs Association “Patent Practice in Pharma Industry that Legal Department Must Know&#8221 […]


On July 13th, 2015, Masahiro Nanjo gave a lecture on “Supreme Court Decision on Product-By-Process Claims and Future Practice” for Pharma & Biotech Patent Cases Research Group in Japan Patent Attorney Association.

whatsnew_seminars_EN-2

On July 13th, 2015, Masahiro Nanjo gave a lecture on “Supreme Court Decision on Product-By-Process Claims and Future Practice” for Pharma & Biotech Patent Cases Research Group in Japan Patent Attorney Association. Pharma & Biotech Patent Cases Research Group,Japan Patent Attorney Association. “Supreme Court Decision on Product-By-Process Claims and Future Practice” […]


On July 2nd, 2015, Masahiro Nanjo will gave a lecture on a theme “Various Aspects of Inventions Originating from Academic Sector in view of Patent” for a symposiums in the 31st Annual Meeting of Japan Society of Drug Delivery System.

whatsnew_seminars_EN-2

On July 2nd, 2015, Masahiro Nanjo will gave a lecture on a theme “Various Aspects of Inventions Originating from Academic Sector in view of Patent” for a symposiums in the 31st Annual Meeting of Japan Society of Drug Delivery System. 31st Annual Meeting of Japan Society of Drug Delivery System “Various Aspects of Inventions Originating from Academic Sector in view of Patent&#8221 […]


On January 9th, 2015, Masahiro Nanjo reported on a theme “Study on Consideration of Advantageous Effect Based on Experimental Data Obtain After Filing” -as trigered by Bristol Myers Squibb Co. v. Teva Pharmaceuticals (Federal Circuit No. 2013-1306)-” for Working Group on “Further Research on Inventive Step”, Central Research Institute of Intellectual Property, Japan Patent Attorneys Association.

whatsnew_seminars_EN-2

On January 9th, 2015, Masahiro Nanjo reported on a theme “Study on Consideration of Advantageous Effect Based on Experimental Data Obtain After Filing” -as trigered by Bristol Myers Squibb Co. v. Teva Pharmaceuticals (Federal Circuit No. 2013-1306)-” for Working Group on “Further Research on Inventive Step”, Central Research Institute of Intellectual Property, Japan P […]


On April 26th, Masahiro Nanjo reported on ” Problems of our Patent Law in view of Inherency Doctrine in the US” for Working Group on Specification Endurable in Patent Enformecent, Central Research Institute of Intellectual Property, Japan Patent Attorneys Association.

whatsnew_seminars_EN-2

On April 26th, Masahiro Nanjo reported on “Problems of our Patent Law in view of Inherency Doctrine in the US” for Working Group on Specification Endurable in Patent Enformecent, Central Research Institute of Intellectual Property, Japan Patent Attorneys Association.


On November 9th in Osaka, Masahiro Nanjo served as a panelist in “Various Issues regarding Specification,” a panel discussion at the 10th Public Forum (in Osaka, Japan), held by the Central Research Institute of Intellectual Property of the Japan Patent Attorneys Association, and presented a research report on “Interpretation of product-by-process claims in Japan” on the interpretation of product-by-process claims. The coordinator for this panel discussion in Osaka was Prof. Ryu Takabayashi of Waseda University.

whatsnew_seminars_EN-2

On November 9th in Osaka, Masahiro Nanjo served as a panelist in “Various Issues regarding Specification,” a panel discussion at the 10th Public Forum (in Osaka, Japan), held by the Central Research Institute of Intellectual Property of the Japan Patent Attorneys Association, and presented a research report on “Interpretation of product-by-process claims in Japan” on the in […]


On November 9th in TOKYO, Masahiro Nanjo served as a panelist in “Various Issues regarding Specification,” a panel discussion at the 10th Public Forum (in Tokyo, Japan), held by the Central Research Institute of Intellectual Property of the Japan Patent Attorneys Association, and presented a research report on “Interpretation of product-by-process claims in Japan” on the interpretation of product-by-process claims. The coordinator for this panel discussion in Osaka was Prof. Tetsuya Obuchi of the University of TOKYO.

whatsnew_seminars_EN-2

On November 9th in TOKYO, Masahiro Nanjo served as a panelist in “Various Issues regarding Specification,” a panel discussion at the 10th Public Forum (in Tokyo, Japan), held by the Central Research Institute of Intellectual Property of the Japan Patent Attorneys Association, and presented a research report on “Interpretation of product-by-process claims in Japan” on the in […]


Masahiro Nanjo gave a lecture, “Theory and Practice on Use Inventions in the Pharmaceutical and Chemical fields” for the mandatory training program for patent attorneys held by the Education Institute of the Japan Patent Attorneys Association. This lecture is to be distributed by the Japan Patent Attorneys Association as e-learning on the web as part of the mandatory training program for patent attorneys.

whatsnew_seminars_EN-2

Masahiro Nanjo gave a lecture, “Theory and Practice on Use Inventions in the Pharmaceutical and Chemical fields” for the mandatory training program for patent attorneys held by the Education Institute of the Japan Patent Attorneys Association. This lecture is to be distributed by the Japan Patent Attorneys Association as e-learning on the web as part of the mandatory training program f […]


On December 21st, Masahiro Nanjo reported on “Pharmaceutical companies and Patents, -From Basics to Advanced” in the 6th Lecture in Legal Practice Course held by Japan Pharmaceutical Industry Legal Affairs Association.

whatsnew_seminars_EN-2

On December 21st, Masahiro Nanjo reported on “Pharmaceutical companies and Patents, -From Basics to Advanced” in the 6th Lecture in Legal Practice Course held by Japan Pharmaceutical Industry Legal Affairs Association.


On July 24th, Masahiro Nanjo reported on “A review on a proposition if the enablement requirement has to be satisfied within the whole claimed range, and the significance thereof” for Working Group on Various Issues Involving Specification, Central Research Institute of Intellectual Property, Japan Patent Attorneys Association.

whatsnew_seminars_EN-2

On July 24th, Masahiro Nanjo reported on “A review on a proposition if the enablement requirement has to be satisfied within the whole claimed range, and the significance thereof” for Working Group on Various Issues Involving Specification, Central Research Institute of Intellectual Property, Japan Patent Attorneys Association.


SEARCH OUR WEB

FAQs

Click the image for FAQ!

CATEGORY